Вазовагальные синкопальные состояния: от основ патогенеза к лечению

Вазовагальные синкопальные состояния: от основ патогенеза к лечению

Автор: Барсуков А.В., Глуховской Д.В., Чепчерук О.Г.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 3 т.12, 2017 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188682

IDR: 140188682

Список литературы Вазовагальные синкопальные состояния: от основ патогенеза к лечению

  • Барсуков А.В. Синкопальные состояния как сфера профессиональных интересов врача-кардиолога/А.В.Барсуков, Д.В.Глуховской, О.Г.Чепчерук, М.В.Диденко, А.Л.Бобров//Вестник Российской военно-медицинской академии. -2016. -№3(55). -С. 251-259.
  • Барсуков А.В. Немедикаментозные методы профилактики и лечения нейрокардиогенных синкопальных состояний/А.В. Барсуков, М.В. Диденко, К.Н. Шорохов, Г.Г.Хубулава//Вестник восстановительной медицины. -2008. -№5 -C. 23-28.
  • Попов В.Л. Синкопальные состояния в практике судебно-медицинской экспертизы при расследовании дорожно-транспортных происшествий/В.Л.Попов, А.В.Барсуков, А.И.Сергеев, Р.В.Петров//Альманах судебной медицины. -2016. -№30 (38). -С. 29-42
  • Тюрина Т.В. Особенности нейрокардиогенных обмороков разных типов у больных с нарушениями регуляции артериального давления/Т.В.Тюрина//Вестник аритмологии. -2005. -№ 37. -С. 14-19.
  • Хирманов В.Н. Распознавание и лечение нейрокардиогенных обмороков злокачественного течения/В.Н.Хирманов, Т.В.Тюрина//Терапевтический архив. -2002. -№ 4. -С. 78-80.
  • Barön-Esquivias G. Long-term outcome of patients with asystole induced by head-up tilt test/G.Barón-Esquivias, A.Pedrote, A.Cayuela //European Heart Journal. -2002. -Vol. 23, suppl. 6. -P. 483-489.
  • Blanc J.J. Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?/J.J. Blanc//Progress in Cardiovascular Diseases. -2013. -Vol. 55. -P. 418-424.
  • Brignole M. Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes/Brignole M., Ammirati F., Arabia F. //European Heart Journal. -2015. -Vol. 36, suppl. 24. -P. 1529-1535.
  • Brignole M. Prospective multicenter systematic guideline-based management of patients referred to the syncope units of general hospitals/M. Brignole //Europace. -2010. -Vol. 12. -109-118.
  • Brignole M. International Study on Syncope of Uncertain Etiology (ISSUE) 2 Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope/M. Brignole, R. Sutton, C. Menozzi et al.//European Heart Journal. -2006. -Vol.27. -P. 1085-1092.
  • Brignole M. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3)/M. Brignole, P. Donateo, M. Tomaino //Circulation: Arrhythmia and Electrophysiology. -2014. -Vol. 7. -P. 10-16.
  • Brignole M. Different electrocardiographic manifestations of the cardioinhibitory vasovagal reflex/M. Brignole//Europace. -2009. Vol. 11, suppl.2. -P. 144-146.
  • Brignole M. Early application of an implantable loop recorder allows a mechanism-based effective therapy in patients with recurrent suspected neurally mediated syncope/M.Brignole, R.Sutton, C.Menozzi //European Heart Journal. -2006. -Vol. 27. -P. 1085-1092.
  • Brignole M. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope/M. Brignole, F. Croci, C. Menozzi //American Journal of Cardiology. -2002. -Vol.40. -P. 2053-2059.
  • Brignole M. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study/M.Brignole, C.Menozzi, A.Del Rosso //Europace. -2000. -Vol. 2, suppl. 1. -P. 66-76.
  • Brignole M. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial/M.Brignole, C.Menozzi, A.Moya //Circulation. -2012. -Vol.125, suppl.21. -P. 2566-2571.
  • Bonzi M. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis/M.Bonzi, E.M.Fiorelli, L.Furlan //International Journal of Cardiology. -2013. -Vol. 168. -623 р.
  • Carvalho M.S. Prognostic value of a very prolonged asystole during head-up tilt test/M.S.Carvalho, K.Reis Santos, P.Carmo //Pacing and Clinical Electrophysiology. -2015. -Vol. 38, suppl. 8. -P. 973-979.
  • Connolly S.J. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial/S.J. Connolly, R. Sheldon, K.E. Thorpe //JAMA. -2003. -Vol.289, suppl.17. -P. 2224-2229.
  • Connolly S.J. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope/S.J.Connolly, R.Sheldon, R.S.Roberts, M.Gent//Journal of the American College of Cardiology. -1999. -Vol. 33, suppl. 1. -P. 16-20.
  • da Silva R.M. The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope/R.M. da Silva//The Open Cardiovascular Medicine Journal. -2016. -Vol.10. -P. 179-187.
  • Deharo J.C. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test/J.C.Deharo, C.Jego, A.Lanteaume, P.Djiane//Journal of the American College of Cardiology. -2006. -Vol.47, suppl.3. -P. 587-593.].
  • Edvardsson N. Unexplained Syncope: Implications of Age and Gender on Patient Characteristics and Evaluation, the Diagnostic Yield of an Implantable Loop Recorder, and the Subsequent Treatment/N.Edvardsson, C. Garutti, Rieger G.//Clinical Cardiology. -2014. -Vol.37, suppl.10. -P. 618-625.
  • Farwell D.J. The clinical impact of implantable loop recorders in patients with syncope/D.J. Farwell, N. Freemantle, N. Sulke//European Heart Journal. -2006. -Vol.27. -P. 351-356.
  • Foglia-Manzillo G. Reproducibility of asystole during head-up tilt testing in patients with neurally mediated syncope/G.Foglia-Manzillo, M.Romanô //Europace. -2002. -Vol.4, suppl.4. -P. 365-367.
  • Forleo C. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis/C. Forleo, P. Guida, M. Iacoviello //International Journal of Cardiology. -2013. -Vol.168. -P. 27-35.
  • Fu Q. Pathophysiology of neurally mediated syncope: Role of cardiac output and total peripheral resistance/Q. Fu, B.D. Levine//Autonomic Neuroscience: Basic and Clinical. -2014. -Vol. 184. -P. 24-26.
  • Furukawa T. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope/T. Furukawa, R. Maggi, C. Bertolone //Journal of Cardiovascular Electrophysiology. -2012. -Vol.23, suppl. 1. -P. 67-71.
  • Galizia G. Role of early symptoms in assessment of syncope in elderly people: results from the Italian Group for Study of Syncope in the Elderly/G. Galizia, P. Abete, C. Mussi. //Journal of the American Geriatrics Society. -2009. -Vol. 57. -P. 8-23.
  • Guaraldi P. Tilt-induced cardioinhibitory syncope: a follow-up study in 16 patients/P.Guaraldi, G.Calandra-Buonaura, R.Terlizzi //Clinical Autonomic Research. -2012. -Vol. 22, suppl. 3. -P. 155-160.
  • Jardine D.L. Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope/D.L. Jardine, I.C. Melton, I.G. Crozier //American Journal of Physiology Heart and Circulation Physiology. -2002. -Vol. 282. -P.1804-1809.
  • Krahn A.D. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial/A.D. Krahn, G.J. Klein, R. Yee //Journal of the American College of Cardiology. -2003. -Vol.42. -P. 495-501.
  • Kuriachan V. Evidence-based treatment for vasovagal syncope/V. Kuriachan, R.S. Sheldon, M. Platonov//Heart Rhythm. -2008. -Vol.5. -P. 1609-1614.
  • Lacroix D. Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic implications/D.Lacroix, C.Kouakam, D.Klug //Pacing and Clinical Electrophysiology. -1997. -Vol. 20, suppl. 11. -P. 2746-2754.
  • Mosqueda-Garcia R. The elusive pathophysiology of neurally mediated syncope/R.Mosqueda-Garcia, R.Furlan, J.Tank //Circulation. -2000. -Vol. 102. -P. 2898-2906.
  • Moya A. Pacemaker therapy in syncope/A.Moya, I.Roca-Luque, J.Francisco-Pascual //Cardiology Clinics. -2013. -Vol. 31, suppl. 1. -P. 131-142.
  • Natale A. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope/A.Natale, M.Akhtar, M.Jazayeri //Circulation. -1995. -Vol. 92. -P. 54-58.
  • Rafanelli M. Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls/M. Rafanelli, E. Ruffolo, V.M. Chisciotti //Aging Clinical and Experimental Research. -2014. -Vol. 26. -P. 33-37.
  • Raj S.R. Rationale for the prevention of syncope trial IV: assessment of midodrine/S.R. Raj, P.D. Faris, M. McRae, R.S. Sheldon//Clinical Autonomic Research. -2012. -Vol.22. -P. 275-280.
  • Raj S.R. The Second Prevention of Syncope Trial (POST II) -a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design/S.R Raj., S.Rose, D.Ritchie //Am Heart J. -2006. -Vol. 151, suppl. 1186. -P. 11-17.
  • Romme J.J. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial)/J.J. Romme, N. van Dijk, I.K. Go-Schon //Europace. -2011. -Vol.13. -P. 1639-1647.
  • Romme J.J. Influence of age and gender on the occurrence and presentation of reflex syncope/J.J Romme., N. van Dijk, K.R. Boer //Clinical Autonomic Research. -2008. -Vol. 18. -P. 128-133.
  • Samniah N. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope/N. Samniah, S. Sakaguchi, K.G. Lurie //American Journal of Cardiology. -2001. -Vol. 88(A7). -P. 80-83.
  • Schleifer J.W. Vasovagal syncope: an update on the latest pharmacological therapies/J.W.Schleifer, W.K. Shen//Expert Opinion on Pharmacotherapy. -2015. -Vol. 16, № 4. -P. 501-513.
  • Serletis A. Vasovagal syncope in medical students and their first-degree relatives/A. Serletis, S. Rose, A.G. Sheldon, R.S. Sheldon//European Heart Journal. -2006. -Vol. 27. -P. 1965-1970.
  • Sheldon R. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope/Sheldon R.S., Grubb B.P., Olshansky B. //Heart Rhythm. -2015. -Vol.12, suppl. 6. -P.e41-e63.
  • Sheldon R. Age-dependent effect of beta-blockers in preventing vasovagal syncope/R. Sheldon, C.A. Morillo, T. Klingenheben //Circulation: Arrhythmia and Electrophysiology. -2012. -Vol.5. -P. 920-926.
  • Sheldon R. Diagnostic criteria for vasovagal syncope based on a quantitative history/R. Sheldon, S. Rose, S. Connolly //European Heart Journal. -2006. -Vol. 27. -P. 344-350.
  • Sheldon R. How to differentiate syncope from seizure/R. Sheldon//Cardiac Electrophysiology Clinics. -2012. -Vol.5. -P. 423-431.
  • Sheldon R. Investigators of the Syncope Symptom Study and the Prevention of Syncope Trial. Age of first faint in patients with vasovagal syncope/R. Sheldon, A.G. Sheldon, S.J. Connolly //Journal of Cardiovascular Electrophysiology. -2006. -Vol.17. -P. 49-54.
  • Sheldon R. Syncope outcomes in a national health database: low risk is not no risk/R. Sheldon//Journal of the American College of Cardiology. -2013. -Vol. 61, suppl. 3 -P. 333-334.
  • Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med 2002; 347(12): 878-85; Baron-Esquivias G, Errázquin F, Pedrote A, et al. Long-term outcome of patients with vasovagal syncope. Am Heart J 2004;147(5): 883-9.
  • Sud S. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope/S. Sud, G.J. Klein, A.C. Skanes //Europace. -2007. -Vol. 9. -P. 312-318.
  • Sumner G.L. Prevention of Syncope Trial I Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden/G.L. Sumner, M.S. Rose et al.//Journal of Cardiovascular Electrophysiology. -2010. -Vol. 21. -P. 1375-1380
  • Sutton R. International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators Cardiac pacing in patients with neurally mediated syncope and documented asystole: effectiveness analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) Registry/R.Sutton, A.Ungar, P. Sgobino //Europace. -2014. -Vol.16, suppl.4. -P. 595-599.
  • Sutton R. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis/R.Sutton, M.Brignole//European Heart Journal. -2014. -Vol. 35, suppl. 33. -P. 2211-2212.
  • Sutton R. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope/R.Sutton, T.V. Salukhe, A.C. Franzen-McManus //Europace. -2014. -Vol. 16. -P. 284-288.
  • Takata T.S. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers/T.S. Takata, S.L. Wasmund, M.L. Smith //Circulation. -2002. -Vol. 106. -P. 1500-1504.
  • Theodorakis G.N. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study/G.N. Theodorakis, D. Leftheriotis, E.G. Livanis et al.//Europace. -2006. -Vol. 8. -P. 193-198.
  • Thomson H.L. Failure of reflex venoconstriction during exercise in patients with vasovagal syncope/H.L. Thomson, J.J. Atherton, F.A. Khafagi, M.P. Frenneaux//Circulation. -1996. -Vol. 93. -P. 953-959.
  • Udo E.O. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study/E.O.Udo, N.P. Zuithoff //Heart Rhythm. -2012. -Vol.9, suppl. 5. -P. 728-735.
  • Vaddadi G. Persistence of muscle sympathetic nerve activity during vasovagal syncope/G. Vaddadi, M.D. Esler, T. Dawood, E. Lambert//European Heart Journal. -2010. -Vol. 31. -P. 2027-2033.
  • Vaddadi G. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes/G. Vaddadi, L. Guo, M. Esler et al.//Circulation: Arrhythmia and Electrophysiology. -2011. -Vol. 4. -P. 711-718.
  • van Dijk N. High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study/N. van Dijk, K.R. Boer, N. Colman, A. Bakker et al.//Journal of Cardiovascular Electrophysiology. -2008. -Vol. 19. -P. 48-55.
  • van Dijk N. PC-Trial Investigators. Effectiveness of physical counter pressure maneuvers in preventing vasovagal syncope: the Physical Counter pressure Manoeuvres Trial (PC-Trial)/N. van Dijk, F. Quartieri, J.J. Blanc et al.//American Journal of Cardiology. -2006. -Vol. 48. -P. 1652-1657.
  • Verheyden B. Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope/Verheyden B, Liu J, van Dijk N. //Heart Rhythm. -2008. -Vol. 5. -P. 1695-1701.
  • Vyas A. Are treatments for vasovagal syncope effective? A meta-analysis/A. Vyas, P.D. Swaminathan, M.B. Zimmerman, B. Olshansky//International Journal of Cardilogy. -2013. -Vol. 167. -P. 1906-1911.
Еще
Статья
SciUp 2024 © 2024 ©